Seung Min Yang

Title: Innovations by Seung Min Yang in Histone Lysine Demethylation

Introduction

Seung Min Yang is an accomplished inventor based in Yongin, South Korea. He holds a notable patent that contributes to the fields of biochemistry and pharmacology. His work primarily focuses on modulating histone lysine demethylases (KDMs), which are critical in the regulation of various diseases.

Latest Patents

Yang's significant patent is titled "Pyridopyrimidinone compounds for modulating the catalytic activity of histone lysine demethylases (KDMs)." This invention presents a compound, described by Formula (I), which effectively modulates the activity of KDMs. The compound acts as a potent inhibitor of KDMs, demonstrating exceptional potential for pharmaceutical intervention in treating cancer and other diseases associated with KDM dysregulation. The patent outlines not only the compound but also pharmaceutical compositions, preparation methods, and its application as a medicament.

Career Highlights

Seung Min Yang works at Dong-A Socio Holdings Corporation, a well-regarded company in the pharmaceutical sector. His career is marked by his innovative approach to developing therapeutic solutions that leverage in-depth knowledge of biochemical mechanisms. His work has made a substantial impact in the fields of medicine and therapeutic science.

Collaborations

Yang collaborates with esteemed colleagues such as Myeong-seop Kim and Taesun Park, who assist in advancing the research and development of his inventions. Together, they contribute to a collaborative environment that fosters innovation and scientific discovery within their organization.

Conclusion

Seung Min Yang's contributions to the field of pharmaceutical innovation, particularly through his patent on KDM modulating compounds, exhibit his dedication to exploring new treatments for significant health challenges. His work continues to inspire and pave the way for future advancements in the biopharmaceutical industry.